{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:31:38Z","timestamp":1786984298381,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim GmbH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.amjcard.2022.03.050","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T07:26:29Z","timestamp":1652081189000},"page":"58-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Comparison of Dabigatran Versus Warfarin Treatment for Prevention of New Cerebral Lesions in Valvular Atrial Fibrillation"],"prefix":"10.1016","volume":"175","author":[{"given":"Min Soo","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minsu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-ah","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahmin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Min","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gi-Byoung","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duk-Hyun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kee-Joon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2022.03.050_bib0001","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.amjcard.2022.03.050_bib0002","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/eurheartj\/ehi667","article-title":"Effect of antithrombotic therapy in patients with mitral stenosis and atrial fibrillation: a sub-analysis of NASPEAF randomized trial","volume":"27","author":"P\u00e9rez-G\u00f3mez","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2022.03.050_bib0003","doi-asserted-by":"crossref","first-page":"885","DOI":"10.7326\/0003-4819-128-11-199806010-00001","article-title":"Predictors of systemic embolism in patients with mitral stenosis. A prospective study","volume":"128","author":"Chiang","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2022.03.050_bib0004","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2022.03.050_bib0005","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2022.03.050_bib0006","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2022.03.050_bib0007","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"ENGAGE AF-TIMI 48 Investigators. Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2022.03.050_bib0008","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2022.03.050_bib0009","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Van de Werf F, RE-ALIGN Investigators. Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2022.03.050_bib0010","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2018.12.047","article-title":"Outcomes of direct oral anticoagulants in patients with mitral stenosis","volume":"73","author":"Kim","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2022.03.050_bib0011","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jacc.2017.03.011","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice guidelines","volume":"70","author":"Nishimura","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2022.03.050_bib0012","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","article-title":"The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"39","author":"Steffel","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2022.03.050_bib0013","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1161\/STR.0000000000000116","article-title":"Prevention of stroke in patients with silent cerebrovascular disease: a scientific statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"48","author":"Smith","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.amjcard.2022.03.050_bib0014","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2014.12.018","volume":"66","author":"Hicks","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2022.03.050_bib0015","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.amjcard.2022.03.050_bib0016","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jacc.2004.05.084","article-title":"Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study","volume":"44","author":"P\u00e9rez-G\u00f3mez","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2022.03.050_bib0017","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.014807","article-title":"Apixaban in comparison with warfarin in patients with atrial fibrillation and valvular heart disease: findings from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (Aristotle) trial","volume":"132","author":"Avezum","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2022.03.050_bib0018","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.02.018","article-title":"Non-vitamin k antagonist oral anticoagulants do not increase cerebral microbleeds","volume":"24","author":"Saito","year":"2015","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.amjcard.2022.03.050_bib0019","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/CIRCULATIONAHA.115.020950","article-title":"Comparison of dabigatran and warfarin in patients With atrial fibrillation and valvular heart disease: the RE-LY trial (randomized evaluation of long-term anticoagulant therapy)","volume":"134","author":"Ezekowitz","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2022.03.050_bib0020","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1212\/WNL.46.1.159","article-title":"Silent brain infarction in nonrheumatic atrial fibrillation. European atrial fibrillation Trial","volume":"46","author":"Study Group","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.amjcard.2022.03.050_bib0021","doi-asserted-by":"crossref","first-page":"650","DOI":"10.7326\/M14-0538","article-title":"Association between atrial fibrillation and silent cerebral infarctions: a systematic review and meta-analysis","volume":"161","author":"Kalantarian","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2022.03.050_bib0022","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2019.03.013","article-title":"Risk factors and localization of silent cerebral infarction in patients with atrial fibrillation","volume":"16","author":"Miki","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.amjcard.2022.03.050_bib0023","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ahj.2015.03.016","article-title":"Predictors of silent brain infarction on magnetic resonance imaging in patients with nonvalvular atrial fibrillation: a transesophageal echocardiographic study","volume":"169","author":"Sugioka","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2022.03.050_bib0024","doi-asserted-by":"crossref","first-page":"8","DOI":"10.15420\/aer.2018.75.2","article-title":"Atrial fibrillation and dementia: exploring the association, defining risks and improving outcomes","volume":"8","author":"Bunch","year":"2019","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"10.1016\/j.amjcard.2022.03.050_bib0025","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3988\/jcn.2007.3.3.147","article-title":"Silent microbleeds and hemorrhagic conversion of an embolic infarction","volume":"3","author":"Kim","year":"2007","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.amjcard.2022.03.050_bib0026","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1161\/hs0302.104615","article-title":"Old microbleeds are a potential risk factor for cerebral bleeding after ischemic stroke: a gradient-echo T2*-weighted brain MRI study","volume":"33","author":"Nighoghossian","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.amjcard.2022.03.050_bib0027","first-page":"324","article-title":"Thrombogenicity of polyethylene oxide-bonded Dacron sewing ring in a mechanical heart valve","volume":"8","author":"Dewanjee","year":"1999","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.amjcard.2022.03.050_bib0028","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/europace\/eux240","volume":"19","author":"Lip","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.amjcard.2022.03.050_bib0029","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.CIR.45.4.878","article-title":"Natural history of mitral stenosis: a review","volume":"45","author":"Selzer","year":"1972","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2022.03.050_bib0030","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1586\/14779072.2014.960851","article-title":"Distribution of thromboembolism in valvular versus non-valvular atrial fibrillation","volume":"12","author":"Blustin","year":"2014","journal-title":"Expert Rev Cardiovasc Ther"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914922004027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914922004027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:42:03Z","timestamp":1757572923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914922004027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":30,"alternative-id":["S0002914922004027"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2022.03.050","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Dabigatran Versus Warfarin Treatment for Prevention of New Cerebral Lesions in Valvular Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2022.03.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}